Hindgut-derived endoderm can differentiate into rectal, prostatic, and bladder phenotypes. Stromalepithelial interactions are crucial for this development; however, the precise mechanisms by which epithelium responds to stromal cues remain unknown. We have previously reported ectopic expression of peroxisome proliferator-activated receptor-g2 (PPARg2) increased androgen receptor expression and promoted differentiation of mouse prostate epithelium. PPARg is also implicated in urothelial differentiation. Herein we demonstrate that knockdown of PPARg2 in benign human prostate epithelial cells (BHPrEs) promotes urothelial transdifferentiation. Furthermore, in vitro and in vivo heterotypic tissue regeneration models with embryonic bladder mesenchyme promoted urothelial differentiation of PPARg2-deficient BHPrE cells, and deficiency of both PPARg isoforms 1 and 2 arrested differentiation. Because PTEN deficiency is cooperative in urothelial pathogenesis, we engineered BHPrE cells with combined knockdown of PPARg and PTEN and performed heterotypic recombination experiments using embryonic bladder mesenchyme. Whereas PTEN deficiency alone induced latent squamous differentiation in BHPrE cells, combined PPARg and PTEN deficiency accelerated the development of keratinizing squamous metaplasia (KSM). We further confirmed via immunohistochemistry that gene expression changes in metaplastic recombinants reflected human urothelium undergoing KSM. In summary, these data suggest that PPARg isoform expression provides a molecular basis for observations that adult human epithelium can be transdifferentiated on the basis of heterotypic mesenchymal induction. These data also implicate PPARg and PTEN inactivation in the development of KSM. (Am J Pathol 2013, 182: 449e459; http://dx
Hindgut-derived endoderm can differentiate into rectal, prostatic, and bladder phenotypes. Stromalepithelial interactions are crucial for this development; however, the precise mechanisms by which epithelium responds to stromal cues remain unknown. We have previously reported ectopic expression of peroxisome proliferator-activated receptor-g2 (PPARg2) increased androgen receptor expression and promoted differentiation of mouse prostate epithelium. PPARg is also implicated in urothelial differentiation. Herein we demonstrate that knockdown of PPARg2 in benign human prostate epithelial cells (BHPrEs) promotes urothelial transdifferentiation. Furthermore, in vitro and in vivo heterotypic tissue regeneration models with embryonic bladder mesenchyme promoted urothelial differentiation of PPARg2-deficient BHPrE cells, and deficiency of both PPARg isoforms 1 and 2 arrested differentiation. Because PTEN deficiency is cooperative in urothelial pathogenesis, we engineered BHPrE cells with combined knockdown of PPARg and PTEN and performed heterotypic recombination experiments using embryonic bladder mesenchyme. Whereas PTEN deficiency alone induced latent squamous differentiation in BHPrE cells, combined PPARg and PTEN deficiency accelerated the development of keratinizing squamous metaplasia (KSM). We further confirmed via immunohistochemistry that gene expression changes in metaplastic recombinants reflected human urothelium undergoing KSM. In summary, these data suggest that PPARg isoform expression provides a molecular basis for observations that adult human epithelium can be transdifferentiated on the basis of heterotypic mesenchymal induction. These data also implicate PPARg and PTEN inactivation in the development of KSM. Bidirectional communication between epithelial and stromal tissue compartments is essential for normal organ development and tissue differentiation. In the context of developmental biology, mesenchyme has been historically classified as having the ability to act in either a permissive or instructive manner. 1 Permissive mesenchyme enables the epithelium to follow a default preprogramed developmental fate, and instructive mesenchyme induces the epithelium to adopt an alternative developmental fate. The ability of mesenchyme to act either permissively or instructively is often tested through implementation of tissue recombination experiments, which can be homotypic (matched mesenchyme and epithelium) or heterotypic. 2 Landmark tissue recombination studies using embryonic urogenital sinus mesenchyme (UGM) and either embryonic urogenital epithelium or adult bladder urothelium have demonstrated that the urothelium could be instructed to form prostate-like acini. 3e7 Studies have also shown that prostatic differentiation is dependent on expression of a functional androgen receptor (AR) in the stromal compartment. 8 Although important discoveries have been made insofar as the molecular program required for prostate development and differentiation, insights into epithelial and stromal factors important for bladder development and urothelial differentiation have been generally lacking. The identification of pathways important for normal bladder development and urothelial differentiation has important implications for developmental biology, tissue regeneration, and malignancy. 9, 10 Recent studies have identified specific molecular pathways in normal bladder development and urothelial response to injury; however, tissue regeneration using genetically manipulated epithelial and stromal components has rarely been applied to determine their importance in bladder development.
The peroxisome proliferator-activated receptor-g (PPARg) and phosphatase and tensin homologue deleted on chromosome ten (PTEN) pathways are important modulators of cellular energy balance that have been implicated repeatedly in urothelial and prostate differentiation and malignancy. PPARg is expressed as two isoforms, which are tissue specific.
11 PTEN is commonly lost or mutated in prostate and bladder disease, 12, 13 which suggests that it has an important role in the maintenance of differentiation. When combined with inhibition of epidermal growth factor receptor, a pathway repressed by PTEN, the PPARg agonist troglitazone is associated with increased expression of markers of urothelial differentiation in normal human urothelial cells.
14 An understanding of PPARg activity in urothelial differentiation is potentially important clinically because use of the PPARg agonist pioglitazone is associated with an increased risk of bladder cancer. 15 These studies strongly identified PPARg as an important regulator of the urothelial phenotype but warrant a deeper understanding of the molecular control.
14e20 Inactivation of PTEN has also been implicated in the development of bladder cancer and seems to cooperate with other important genetic changes to drive tumorigenesis. 21, 22 The objective of the present study was to determine the importance of PPARg isoforms and PTEN activity in urogenital differentiation. We adapted three-dimensional (3D) co-culture and in vivo tissue regeneration models using a benign human prostate epithelial cell line (BHPrE) that expresses both PPARg isoforms and regenerates 23 Knockdown experiments demonstrated that PPARg2 is essential for induction of prostate epithelial differentiation by urogenital mesenchyme and that PPARg2-deficient prostate epithelium can be induced by fetal bladder mesenchyme to transdifferentiate into urothelium. Knockdown of both PPARg isoforms 1 and 2 arrested even urothelial differentiation of BHPrE cells. Furthermore, we demonstrated that tissue regeneration of PTEN-deficient BHPrE cells induced focal metaplasia and hyperplasia at 3 months, followed by squamous metaplasia at 6 months. Deficiency of both PTEN and PPARg1/2 cooperated to drive keratinizing squamous metaplasia (KSM) by 3 months, which exhibited a similar deregulation of genes implicated in human KSM. In summary, we used novel tissue regeneration models with genetically manipulated human prostate epithelial cells to reproduce and characterize differentiation to urothelial and KSM phenotypes.
Materials and Methods

Cell Line Generation
Control, PPARg1/2, and PPARg2eshRNA cell lines were generated using the following constructs ( Figure 1A) 
3D Co-Culture and Tissue Regeneration
Three dimentional Cultrex overlay co-culture was performed as described previously. 25 In brief, mesenchymal cells from either 18-day embryonic rat urogenital sinus mesenchyme (rUGM) or 16-day embryonic rat bladder mesenchyme (rBM) were dissociated into single cells using collagenase digestion. Coverslips were coated with 50 mL Cultrex, and BHPrE control and PPARg2sh cells were seeded alone or in co-culture with rUGM or rBM at a ratio of 1:2.5 and overlaid with 2% Cultrex. Media were changed every 3 days, and cultures were grown for 8 days. Immunocytochemistry was performed as described previously. Cells were fixed using 3.7% formaldehyde at room temperature and permeabilized using 0.2% Triton X-100 in PBS for 5 minutes. Then cells were washed three times with PBS-glycine (130 mmol/L NaCl, 7 mmol/L NaHPO 4 , 3.5 mmol/L NaH 2 PO 4 , and 100 mmol/L glycine) and blocked for 1 hour by incubating with an immunofluorescence buffer (130 mmol/L NaCl, 7 mmol/L NaHPO 4 , 3.5 mmol/L NaH 2 PO 4 , 7.7 mmol/L NaN 3 , 0.1% bovine serum albumin, 0.2% Triton X-100, 0.05% Tween 20, and 10% goat serum). In controls, preimmune rabbit or mouse IgG replaced primary antibodies. The cells were double-labeled using antibodies to CK14 (1:50; Vector Laboratories, Inc., Burlingame, CA) and AR (1:40; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) or CK14 and asymmetric unit membraneepan-uroplakin (UP; 1:500; a generous gift from Dr. Xue-Ru Wu, New York University) and incubated overnight, followed by incubation for 1 hour at room temperature using fluorescence-labeled secondary antibody. Cells were then washed and imaged using a water immersion lens on a confocal microscope (LSM 510 META NLO; Carl Zeiss GmbH, Jena, Germany).
Tissue regeneration was performed as described previously. 23, 26 In brief, rUGM from 18-day-old fetal rat pups and rBM from 16-day-old fetal rat pups were dissected and recombined with epithelium for grafting under the renal capsule in nude mice for 3 months. All grafts were repeated a minimum of three times, and results varied insofar as the severity of the phenotypes, as is expected in these types of regenerative studies.
The human origin of cells in tissue recombinants was confirmed via PCR of genomic DNA isolated from scrapings taken from paraffin-embedded sections on glass slides (Supplemental Figure S1) 
Western Blot Analysis
Western blot analysis was performed as described previously. 27 In brief, 40 mg total protein was loaded onto 10% polyacrylamide gels (Life Technologies) and transferred onto nitrocellulose (PerkinElmer, Inc., Waltham, MA). Blots were subsequently blocked in 5% bovine serum albumin in Tris-buffered saline solution and Tween 20 and probed using the following antibodies: CK20 (1:200; Abcam PLC, Cambridge, MA); CK14 (1:500; Vector Laboratories); b-actin (1:2000; Sigma-Aldrich); p63 (1:500), AR (1:500), and PPARg (1:250); all three from Santa Cruz Biotechnology); E-cadherin (1:500; BD Transduction Laboratories, BD Biosciences); and PTEN (1:1000), Akt (1:1000), pAkt (S473) (1:1000), pERK (1:1000), and cyclin D1 (1:1000); all five from Cell Signaling Technology, Inc. (Danvers, MA).
Tissue Acquisition and Immunostaining
Deidentified human bladder tissue samples were obtained from the Translational Pathology Shared Resources Core at the Vanderbilt Ingram Cancer Center in accordance with Vanderbilt University Institutional Review Board protocols. Presence of KSM was verified via pathologic examination by an author (J.M.M.C.). For immunofluorescence, cells in culture were dual immunostained and counted as described previously. 27 Results were statistically analyzed using Student's unpaired t-test using Prism software (GraphPad Prism 4 Software, Inc., La Jolla, CA). In brief, cells were grown to 70% confluence and fixed in 4% paraformaldehyde for 15 minutes, washed, and probed using the following antibodies at 4 C overnight: CK8/18 (1:2000; Fitzgerald Industries International, Acton, MA), CK14 (1:250; Vector Laboratories), and PPARg (1:25; Santa Cruz Biotechnology).
For immunohistochemistry, sections were processed as described previously. 27 In brief, sections were deparaffinized in Histoclear and rehydrated, and endogenous peroxidases were blocked using methanol. After 1 hour of blocking with 5% serum, sections were incubated at 4 C overnight with the following antibodies: PPARg (1:25), AR (1:200), p63 (1:200), and FOXA1 (1:1000); all four from Santa Cruz Biotechnology); E-cadherin (1:1000; BD Transduction Laboratories); pAkt (S473) (1:25) and pERK (1:500); both from Cell Signaling Technology); CK10 (1:500); DakoCytomation; Dako North America, Inc., Carpinteria, CA); CK14 (1:500; Vector Laboratories), and human asymmetric unit membraneepan-UP (1:10,000).
Results
PPARg2 Deficiency in BHPrE Cell Lines Induces Permissive Urothelial Transdifferentiation in Vitro
PPARg1/2 knockdown in mouse prostate epithelium induces autophagy and high-grade prostatic intraepithelial neoplasia both in conditional knockout (KO) transgenic mice and in tissue regeneration studies using inductive UGM. 28, 29 In addition, rescue with PPARg2 in PPARgKO mouse prostate epithelial cells drives AR expression and function. 27 These data suggest that PPARg2 may be an isoform-specific factor important for prostatic differentiation. To determine the effects of PPARg2 isoform deficiency on human prostate epithelium, we generated shRNAs to PPARg1/2 or PPARg2 alone ( Figure 1A ) and stable knockdown cell lines using a BHPrE cell line that we had previously established. 23 We performed tissue regeneration studies using inductive urogenital mesenchyme (rUGM) and either BHPrE control scrambled shRNA knockdown
CTRLsh plus rUGM regenerated prostate structures similar to those previously described (data not shown). 23 Areas of focal metaplasia in BHPrE PPARg2sh recombinants were observed. Some of these areas were composed of a thickened p63 þ AR À epithelium with morphologic features reminiscent of urothelium ( Figure 1, Figure 1D ). Furthermore, knockdown of both PPARg1 and PPARg2 (BHPrE PPARg1/2sh ) showed reduced AR and absence of CK20, which suggested inhibition of both prostate luminal and urothelial umbrella cell differentiation. Dual immunofluorescence revealed that most BHPrE CTRLsh cells in culture expressed PPARg1/2 (data not shown) and that subpopulations were positive for the basal and luminal epithelial markers CK14 or CK8/18, respectively ( Figure 1E ). In BHPrE PPARg2sh cells, there was a slight increase in CK14 þ cells and a substantial decrease in CK8/18 þ cells (Figure 1, F and G) . These data suggest that our pooled epithelial cell lines have additional cellular subtypes in addition to CK14/p63 þ and CK18/20 þ cells that may support cellular differentiation in a PPARg-dependent manner. PPARg1/2-deficient cells expressed low levels of all differentiation markers examined, which suggests the possibility that PPARg1 is necessary for both prostate and urothelial differentiation.
Previous studies have demonstrated the developmental plasticity of hindgut-derived epithelium in response to various mesenchyma. 4, 5, 7 To determine whether PPARg2-deficient human prostate epithelium was responsive to induction by fetal bladder mesenchyme, we adapted a novel in vitro 3D Cultrex 
PPARg and PTEN Deficiency and KSM
The American Journal of Pathology -ajp.amjpathol.orgoverlay co-culture system 25 in which dissociated cells from inductive fetal urogenital or bladder mesenchyme were plated under Cultrex-embedded epithelium and grown for 8 days. As expected from previous tissue recombination studies performed in vivo, 23 homotypic co-culture of rUGM with BHPrE CTRLsh prostate epithelium regenerated luminized AR þ glandular epithelium surrounded by CK14 þ basal cells (Figure 2 , AeC). Predominantly AR þ acini were observed in BHPrE CTRLsh co-cultures with rBM as well (Figure 2 , DeF). However, BHPrE PPARg2sh epithelium co-cultured with either rBM (Figure 2 , GeI) or rUGM (Figure 2 , JeL) regenerated UP þ cells in approximately 40% of the epithelial structures, which suggested that PPARg2 is necessary for differentiation of prostatic epithelium after co-culture with inductive mesenchyme.
To determine whether PPARg isoform-deficiency was associated with urothelial transdifferentiation in vivo, we recombined inductive bladder mesenchyme with BHPrE 
PTEN Deficiency in BHPrE Cells Drives Epithelial Hyperplasia and Late Squamous Differentiation in Vivo
PTEN loss has been implicated in bladder and prostate diseases and cooperates with multiple other mutations to drive pathologic changes. 21,22,31e34 To determine the effect of PTEN deficiency on regeneration of an human prostate epithelial cell line capable of urothelial transdifferentiation (Figures 2 and 3 ), BHPrE cells were stably transfected with PTEN shRNA, recombined using either bladder or urogenital mesenchyme and regenerated under the renal capsule of immunocompromised mice. (Figure 4 , KeO), BHPrE PTENsh/PPARg1/2 structures were positive for the squamous markers CK10 ( Figure 5B ) and CK14 (not shown) and negative for uroplakin ( Figure 5D ), nuclear PPARg ( Figure 5G) , and the PPARg-regulated urogenital differentiation transcription factor FOXA1 14 ( Figure 5C ), previously demonstrated to be lost in premalignant KSM lesions and squamous cell carcinoma (SCC) of the bladder. 26 , and pAKT 38 demonstrated that even with low PTEN expression, PPARg1/2 deficiency inhibited the activation of AKT, whereas other signaling pathways such as ERK1/2 were still activated ( Figure 5I ). Of note, PPARg1/2 deficiency alone similarly resulted in decreased PTEN expression but was not associated with increased AKT phosphorylation or cyclin D1 levels. We also noted that decreased expression of PPARg1/2 or PPARg2 alone resulted in increased expression of basal cell markers (CK14 and p63), which was diminished when combined with PTEN deficiency. Furthermore, PTEN deficiency was correlated with E-cadherin loss in vitro.
We previously generated a mouse prostate epithelial cell line with genetic ablation of PPARg that contained a 5% population of CK14 þ basal cells (mPrE-PPARgKO) induced by rUGM to form hyperplastic AR þ prostatic acini. 29 Rescue with PPARg2 drove an increased percentage of basal cells and increased differentiation of luminal cells through AR expression and function. 27 To determine whether PTEN deficiency also induced squamous differentiation of mouse prostate epithelium, we generated a stable derivative of mPrE-PPARgKO cells with PTEN knockdown, which resulted in increased expression of basal cell markers including p63 (Supplemental Figure S3A ). When recombined with rUGM for 6 weeks, mPrE-gKO PTENsh cells regenerated a squamous epithelium Figure S3B ) similar to that observed in long-term BHPrE PTENsh (Figure 4 , KeO) and short-term BHPrE PTENsh/PPARg1/2 ( Figure 5AeH ) tissue regeneration experiments.
To confirm whether PPARg and PTEN signaling pathways were similarly disrupted in human keratinizing squamous urothelial metaplasia, we performed immunohistochemistry on human cystectomy samples with histopathologically confirmed KSM for the same proteins analyzed in our human cell line model. We first confirmed the presence of squamous differentiation ( Figure 5L ) and the loss of the urothelial differentiation markers FOXA1 ( Figure 5M ) and uroplakin ( Figure 5N ). We were also able to confirm cytoplasmic PPARg ( Figure 5Q ), low pAKT ( Figure 5R ), and increased pERK ( Figure 5O) ; however, E-cadherin ( Figure 5P ) immunoreactivity was higher than anticipated on the basis of Western blot protein levels in the human cell line model. Similar molecular effects were demonstrated in long-term squamous BHPrE PTENsh grafts, in which FOXA1 was lost, pERK was activated, and PPARg was cytoplasmic (Supplemental Figure S3C) . In summary, we have demonstrated the ability to transdifferentiate human prostate epithelium into urothelium through down-regulation of PPARg2, whereas depletion of both PPARg isoforms causes decreased differentiation of either cell type. Furthermore, induction of squamous differentiation by PTEN is accelerated through combined PPARg1/2 deficiency, which was corroborated in human KSM of the bladder ( Figure 5J ).
Discussion
The data presented herein suggest a role for the regulation of epithelial cellular metabolism in the process of differentiation. We have presented a human tissue regeneration model These data extend observations about the plasticity of hindgut epithelia after heterotypic recombination with embryonic mesenchyma 4, 5, 7 by suggesting that expression of PPARg2 and PTEN is required for maintenance of a prostate epithelial phenotype. Herein we have provided evidence that PPARg2 expression is important for mesenchymal induction of prostate epithelial differentiation because down-regulation of PPARg2 resulted in increased expression of urothelial markers in 3D (Figure 2 ) and in vivo (Figure 3) tissue regeneration experiments after recombination with either urogenital or bladder mesenchyme. These data support our previous observations that ectopic PPARg2 expression in a PPARgKO mouse prostate epithelial cell line promotes differentiation, potentially through a switch from glucose to fatty acid metabolism. 27 We have also demonstrated that knockdown of both PPARg1 and PPARg2 prohibited induction of urothelial differentiation by bladder mesenchyme, which suggests that PPARg1 is minimally necessary for urothelial transdifferentiation and that PPARg2 is not. Knockdown of both PTEN and PPARg1/2 in BHPrE cells recombined with bladder mesenchyme resulted in regeneration of KSM. Metaplastic conversion of human urothelium to a squamous phenotype can be either nonkeratinizing or keratinizing, and this distinction has important clinical ramifications. Whereas non-KSM is common in female patients and tends to develop in the bladder neck or trigone (trigonitis), KSM is a recognized precursor to development of SCC of the bladder. 39 Understanding the molecular events that result in the development of KSM and subsequently SCC is important because this subtype of bladder cancer is particularly aggressive. Immunohistochemical analysis of human tissue acquired from patients with definitive KSM revealed cytoplasmic PPARg expression and increased ERK activation, indicating knockdown of PTEN and PPARg1/2 in BHPrE with subsequent recombination with bladder mesenchyme is capable of modeling this metaplastic event. This conclusion is further supported by immunohistochemical analysis that revealed the presence of E-cadherin and pAKT, and absence of FOXA1, which was previously reported in human KSM. 26 These results indicate that this system recapitulates important molecular events in the development of KSM. This is important because a diagnosis of SCC of the bladder is predictive of poor prognosis in patients with bladder cancer. Biochemical analysis revealed that PTEN deficiency induced AKT activation only in the presence of PPARg1, whereas ERK activation downstream of PTEN deficiency was independent of either PPARg isoform expression ( Figure 5I ). These observations are interesting for many reasons. First, they suggest that PPARg isoforms are important regulators of PI3K/AKT signaling in premalignant KSM. Second, these results suggest that patients with KSM and/or SCC of the bladder may be particularly suited to MAPK pathway inhibition. This is especially interesting inasmuch as local recurrence is the primary cause of death in patients receiving treatment of pure SCC of the bladder, 40 and increased squamous component may increase the likelihood of local recurrence after radical cystectomy. 41 Using human KSM tissue, we were able to confirm the molecular characteristics observed in our human tissue regeneration model by showing increased activated ERK and a decrease in activated AKT signaling.
The role of PTEN loss in SCC is interesting because PTEN inactivation is associated with SCC at several anatomical sites including the head and neck, 42 esophagus 43 , and cervix 44 , and with basal carcinomas of the breast. 45 Pure SCC constitutes approximately 5% of all bladder cancers, whereas 90% of bladder cancers are histologically characterized as urothelial cell carcinomas. Although PTEN inactivation has previously been implicated in urothelial cell carcinomas, our finding that PTEN inactivation cooperates with decreased PPARg signaling to drive metaplastic conversion of urothelium to a squamous phenotype is important because little is known about the molecular mechanisms that mediate the development of KSM and SCC. Our observations need not be limited to KSM and SCC of the bladder because most urothelial cell carcinomas also exhibit some degree of squamous differentiation, and tumors of the upper urinary tract can exhibit mixed or pure squamous histologic features. In summary, we have demonstrated through novel adaptations of in vitro and in vivo tissue recombination and regeneration studies that prostate epithelium can be transdifferentiated into urothelium on the basis of suppression of PPARg2 (Figures 1 and 2) , which can be further transformed into a keratinizing squamous phenotype via decreased PPARg1 and PTEN ( Figure 4 and Figure 5 , AeJ). Moreover, these results mimicked KSM of human bladder ( Figure 5 , KeR) and suggested that loss of PPARg and PTEN may drive proliferation by activation of ERK.
Beyond the specific experimental end points, these observations enable us to speculate about important points relative to cellular differentiation and disease. First, although mesenchymal cells have long been known to drive specific developmental outcomes, the molecular details by which these ends are achieved have not been well understood. Paracrine acting factors that regulate cellular proliferation have been implicated as stromal-epithelial mediators. The observations presented herein are consistent with the idea that such factors could modulate epithelial gene expression, resulting in metabolic changes that affect differentiation. These observations also suggest the possibility that systemic changes in nutritional status might contribute to the destabilization of differentiation, perhaps altering epithelial metabolism contributing to disease-related changes in cell or tissue structure. The stochastic nature of the changes observed, with parts of structures or subpopulations of 3D cultures being affected, also play into the focal nature of some disease entities including some malignant tumors, as well as focal benign conditions such as benign hyperplasia. Future work should focus on development of increased
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